These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19152207)

  • 1. Correlates of stimulant treatment outcome across treatment modalities.
    Peirce JM; Petry NM; Roll JM; Kolodner K; Krasnansky J; Stabile PQ; Brown C; Stitzer ML
    Am J Drug Alcohol Abuse; 2009; 35(1):48-53. PubMed ID: 19152207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
    Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial.
    Magura S; Rosenblum A; Fong C; Villano C; Richman B
    Subst Use Misuse; 2002; 37(14):1927-55. PubMed ID: 12511059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.
    Holtyn AF; Koffarnus MN; DeFulio A; Sigurdsson SO; Strain EC; Schwartz RP; Leoutsakos JM; Silverman K
    Prev Med; 2014 Nov; 68():62-70. PubMed ID: 24607365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment.
    DeMaria PA; Sterling R; Weinstein SP
    Am J Addict; 2000; 9(2):145-53. PubMed ID: 10934576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil for the treatment of cocaine dependence.
    Anderson AL; Reid MS; Li SH; Holmes T; Shemanski L; Slee A; Smith EV; Kahn R; Chiang N; Vocci F; Ciraulo D; Dackis C; Roache JD; Salloum IM; Somoza E; Urschel HC; Elkashef AM
    Drug Alcohol Depend; 2009 Sep; 104(1-2):133-9. PubMed ID: 19560290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients.
    Angelo FN; McDonell MG; Lewin MR; Srebnik D; Lowe J; Roll J; Ries R
    Drug Alcohol Depend; 2013 Jul; 131(1-2):162-5. PubMed ID: 23273776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials.
    McPherson S; Brooks O; Barbosa-Leiker C; Lederhos C; Lamp A; Murphy S; Layton M; Roll J
    J Subst Abuse Treat; 2016 Feb; 61():18-25. PubMed ID: 26456717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
    Trafton JA; Tracy SW; Oliva EM; Humphreys K
    J Stud Alcohol Drugs; 2007 Mar; 68(2):165-72. PubMed ID: 17286334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
    Sobel BF; Sigmon SC; Griffiths RR
    Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of psychoactive substances in women in outpatient treatment.
    Santos JAT; Perruci LG; Pegoraro NPJ; Scherer ZAP; Souza J; Santos MAD; Pillon SC
    Rev Bras Enferm; 2019 Dec; 72(suppl 3):178-183. PubMed ID: 31851251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prize-based contingency management does not increase gambling.
    Petry NM; Kolodner KB; Li R; Peirce JM; Roll JM; Stitzer ML; Hamilton JA
    Drug Alcohol Depend; 2006 Jul; 83(3):269-73. PubMed ID: 16377101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.
    Stitzer ML; Petry NM; Peirce J
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S61-9. PubMed ID: 20307797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
    Ware OD; Sweeney MM; Cunningham C; Umbricht A; Stitzer M; Dunn KE
    JAMA Netw Open; 2023 Mar; 6(3):e232278. PubMed ID: 36920397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-medical stimulant dependence among recent initiates.
    O'Brien MS; Anthony JC
    Drug Alcohol Depend; 2009 Sep; 104(1-2):147-55. PubMed ID: 19515516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.